Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1392 participants
OBSERVATIONAL
2024-06-05
2024-12-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Predictors of One-Year Mortality After Curative Surgery in Patients Aged 80 Years or Older With Non-Metastatic Colorectal Cancer
NCT06704646
RCT on Elderly Patients Undergoing Colorectal Cancer Surgery With Enhanced Geriatric Care
NCT02352688
Effects of Incomplete ERAS on Clinical Outcomes in Patients With Colorectal Cancer
NCT05412355
Effects of Implementing an ERAS Protocol
NCT06010225
Implementation of the ERAS in Colorectal Cancer Patients: a Single Arm Study
NCT06729736
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
traditional care group
traditional care group
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* the procedure was minimally invasive surgery
* they were aged 65 or older
* they provided signed informed consent.
Exclusion Criteria
* Patients with incomplete medical records or missing data relevant to the study.
* Patients with synchronous malignancies or a history of other cancers within the past five years.
* Patients with severe comorbidities (e.g., advanced cardiovascular, respiratory, or renal diseases) that contraindicate ERAS protocol implementation.
* Patients with preoperative metastatic disease or locally advanced tumors requiring palliative procedures.
* Patients who did not comply with or complete the ERAS protocol during the perioperative period.
65 Years
120 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chang Gung Memorial Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chang Gung Memorial Hospital
Taoyuan, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
202401646B0
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.